As of 2026-06-24, the Suboxone® (Buprenorphine / Naloxone) is open. You can check whether you qualify with the free 1-minute eligibility self-check below.
| Case | Suboxone® (Buprenorphine / Naloxone) |
|---|---|
| Status | Open |
| Law firm | Siskinds LLP |
| Jurisdiction | Canada |
| Filing deadline | See case details |
Last verified: 2026-06-24
Buprenorphine/Naloxone, marketed as Suboxone®, is a pharmaceutical drug approved in Canada as a substitution treatment in adults with opioid drug dependence, prescribed as a tablet or film that dissolves in the mouth. Buprenorphine — an active ingredient in Suboxone® — is reported to increase the ri
Check if you qualify →← Browse all 3196+ class actions
This is a free eligibility self-check, not a law firm, not legal advice, and not a lawyer referral service. Using it does not create a lawyer-client relationship.